Stem Cell Industry Resists Strings on CIRM Grants
The California stem cell agency received two distinct messages Wednesday at its first meeting on rules for intellectual property for business.
No blank check for biotech was one admonition (see "ownership") from a watchdog group. The other came from industry, which said don't expect us to come crawling to you for money.
Reporter Lee Romney of the Los Ang…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.